Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a PD-1 antagonist and eribulin for treating cancer

Combination of a PD-1 antagonist and eribulin for treating cancer

US Patent 10945990 · Granted Mar 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for a therapy comprising a sorafenib compound2025
Tumor therapeutic agent2025
Pharmaceutical composition for treating tumor2024
Method for inhibiting tumor growth2024
Linear motion guide unit2023
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2023
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2023
Pharmaceutical composition for treating tumor2021
Biomarkers for predicting and assessing responsiveness of endometrial cancer sub2019
Anti human Notch4 antibody2018
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2018
Biomarkers for predicting and assessing responsiveness of thyroid and kidney can2018